Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2Phase 3 Interventional

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

ClinicalTrials.gov ID: NCT00295802

Public ClinicalTrials.gov record NCT00295802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00295802
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
EDAP TMS S.A.
Industry
Enrollment
141 participants

Conditions and interventions

Interventions

  • Integrated Imaging High Intensity Focused Ultrasound Device
  • Endocare CRYOcare Cryosurgical and Galil Medical CRYO-HIT Systems (cryotherapy) Device

Device

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Jul 31, 2012
Completion
Aug 31, 2014
Last update posted
Feb 6, 2014

2006 – 2014

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Chinn & Chinn Urology Associates Arcadia California 91006
Univeristy of Colorado Hospital and Health Science Center Aurora Colorado 80010
Florida Foundation for Healthcare Research Inc Ocala Florida 34474
Hackensack University Medical Center Hackensack New Jersey 07601
Brooklyn Urology Research Group Brooklyn New York 11215
Sloan-Kettering Institute New York New York 10021
University of North Carolina Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Vanderbilt University Medical Center Nashville Tennessee 37232-2765
Urolgoy Associates of North Texas Arlington Texas 76017
The University of Texas M.D. Anderson Cancer Center Houston Texas 77230
Virginia Urology Center Richmond Virginia 23235
Medical College of Wisconsin, Inc. Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00295802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00295802 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →